EISAI
Information
Science-Driven, Human-Centric.
The ILCA 2025 Annual Conference is shaping up to be a truly exceptional meeting, bringing together leading liver cancer experts from across the globe. Eisai are proud to continue its support as a Principal Sponsor, and we look forward to engaging with delegates and continuing our commitment to innovation in liver cancer.
At Eisai Oncology, we let the science lead us to new approaches that accelerate progress in oncology. This often means pursuing breakthroughs in challenging areas unexplored by other companies. Behind that work is our grounding philosophy rooted in empathy, which is a concept we call human health care (hhc).
Eisai is a Principal Sponsor and has provided financial support for the organisation of ILCA 2025 but has no influence over the scientific content of the meeting.